trial

Cognitive Remediation for First Episode of Psychosis Patients

NCTId NCT01967420
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 40 (actual)
Sponsored by University of Manchester
Primary completion 2015-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
40 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2013-08
Primary completion
2015-07
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
Cognitive RemediationSocial cognition training

Sponsors

University of ManchesterLead Sponsor

Investigators

1
Emily BeetschenPrincipal Investigator

Sites

1 total
Bradford, United Kingdom

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2015-07
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Remediation
drug
Social cognition training
drug
lead_sponsor
University of Manchester
company
indication
Psychosis
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Emily Beetschen
person